All collections

Investor Intelligence

11 Mental Health Investors in Europe

European investors with demonstrated activity across mental-health care, digital therapeutics, neuropsychiatry and technology-enabled treatment.

Published
  • Mental Health
  • Digital Therapeutics
  • Neuropsychiatry
  • Digital Health
  • Europe

Mental-health investing in Europe spans two distinct markets: technology that expands access to care and therapeutics targeting psychiatric or neurological disease. The investor set therefore includes digital-health specialists, impact funds and life-sciences investors with direct exposure.

DealBio selected 11 investors with evidenced relevance to mental health in Europe, using current investor research, financing precedents and public verification where needed.

Azimut Libera Impresa

Italian investment platform backing growth and technology companies through specialist funds.

Stage
Series A
Sector / Focus
Mental health · · Digital health
Investment markets
Italy
Investor type
Investment firm

X-Equity Venture Club

Italian venture investment club backing technology companies.

Stage
Series A
Sector / Focus
Mental health · Virtual care · Digital health
Investment markets
Italy
Investor type
Venture investment club

Serpentine Ventures

Swiss early-stage investor backing technology and science-driven startups.

Stage
Pre-seed
Sector / Focus
Mental health · Neurotechnology
Investment markets
Switzerland
Investor type
VC

Calm/Storm

European early-stage healthtech investor focused on health and wellbeing.

Stage
Pre-seed · Seed · Series A
Sector / Focus
Mental health · Digital health · Wellbeing
Investment markets
Europe
Investor type
VC

Carma Fund

European life-sciences investor backing therapeutics and healthcare innovation.

Stage
Seed
Sector / Focus
Mental health · Depression ·
Investment markets
France · Germany · Sweden
Investor type
VC

TT Ventures

Early-stage venture investor backing technology companies across Europe and Turkey.

Stage
Seed
Sector / Focus
Mental health · Digital therapeutics · Digital health
Investment markets
Turkey · Europe
Investor type
Corporate VC

4impact

European impact VC investing in technology companies with measurable social outcomes.

Stage
Seed
Sector / Focus
Mental health · Digital health · Consumer health
Investment markets
Germany · Europe
Investor type
VC

Access Biotechnology

Life-sciences investment firm backing biotechnology and therapeutics companies.

Stage
Series A
Sector / Focus
Depression · CNS therapeutics · Small molecules
Investment markets
United Kingdom · Europe
Investor type
VC

Gateway Ventures

Austrian investor network and venture platform backing early-stage companies.

Stage
Seed · Series A
Sector / Focus
Neurotechnology · Digital health · Patient monitoring
Investment markets
Austria · Germany
Investor type
VC / Investor network

Moonfire Ventures

European early-stage venture firm using data-led sourcing to invest from pre-seed onward.

Stage
Pre-seed · Seed · Series A
Sector / Focus
Mental health · Digital health
Investment markets
United Kingdom · Europe
Investor type
VC

SICTIC

Swiss angel-investor network backing early-stage technology companies.

Stage
Seed · Series A
Sector / Focus
Mental health · Neurotechnology · Digital health
Investment markets
Switzerland · Europe
Investor type
Angel network

Methodology

DealBio builds investor lists using structured investor research, demonstrated investment activity and current public verification where needed. The methodology highlights investors with evidenced relevance to the article’s sector, stage and geography.

Get the DealBio Pulse

Weekly insights on health and longevity startups, standout founders, key markets, and notable exits.

You can unsubscribe at any time.